A lung cancer molecular prognostic test ready for prime time.
作者信息
Xie Yang, Minna John D
机构信息
Department of Clinical Sciences, University of Texas, Southwestern Medical Center, TX 75390-8593, USA.
出版信息
Lancet. 2012 Mar 3;379(9818):785-7. doi: 10.1016/S0140-6736(12)60154-8.
Abstract
摘要
相似文献
1
A lung cancer molecular prognostic test ready for prime time.一种已准备好投入实际应用的肺癌分子预后检测。
Lancet. 2012 Mar 3;379(9818):785-7. doi: 10.1016/S0140-6736(12)60154-8.
2
Prognostic assay in small, node-negative non-small cell lung cancer.
JAMA. 2013 Feb 27;309(8):769. doi: 10.1001/jama.2012.211724.
3
Prognostic assay in small, node-negative non-small cell lung cancer--reply.
JAMA. 2013 Feb 27;309(8):769-70. doi: 10.1001/jama.2012.211727.
4
A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors.一种预后分析方法，用于识别即使患有小的、无淋巴结转移的肺肿瘤但仍有高死亡风险的患者。
JAMA. 2012 Oct 24;308(16):1629-31. doi: 10.1001/jama.2012.13551.
5
Five-gene signature in non-small-cell lung cancer.
N Engl J Med. 2007 Apr 12;356(15):1582; author reply 1583.
6
Prognostic factors and first-line treatment modalities in nonagenarian patients with lung cancer.
J Geriatr Oncol. 2019 May;10(3):439-441. doi: 10.1016/j.jgo.2018.07.013. Epub 2018 Aug 11.
7
Visceral pleural invasion: a prognostic factor beginning with small size and increasing with the progression of lung cancer.
Ann Thorac Surg. 2014 Jan;97(1):383. doi: 10.1016/j.athoracsur.2013.06.071.
8
Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.整合肿瘤和基质基因表达特征与临床指标用于早期非小细胞肺癌生存分层
J Natl Cancer Inst. 2015 Aug 18;107(10). doi: 10.1093/jnci/djv211. Print 2015 Oct.
9
Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.miRNA 前体基因变异与早期 NSCLC 患者生存的关系
J Thorac Oncol. 2013 Jun;8(6):703-10. doi: 10.1097/JTO.0b013e318288dc0a.
10
Validation of a reverse transcription-polymerase chain reaction-based five-gene signature in non-small cell lung cancer.
J Thorac Oncol. 2009 May;4(5):670. doi: 10.1097/JTO.0b013e3181a1099a.
引用本文的文献
1
An individualized immune prognostic signature in lung adenocarcinoma.肺腺癌中的一种个体化免疫预后特征。
Cancer Cell Int. 2020 May 7;20:156. doi: 10.1186/s12935-020-01237-4. eCollection 2020.
2
Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study.手术肺癌患者循环肿瘤DNA的动态变化：一项前瞻性观察性研究方案
BMJ Open. 2018 Feb 6;8(2):e019012. doi: 10.1136/bmjopen-2017-019012.
3
BARD1 serum autoantibodies for the detection of lung cancer.用于检测肺癌的BARD1血清自身抗体。
PLoS One. 2017 Aug 7;12(8):e0182356. doi: 10.1371/journal.pone.0182356. eCollection 2017.
4
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.早期非鳞状非小细胞肺癌个体化免疫预后标志物的建立与验证。
JAMA Oncol. 2017 Nov 1;3(11):1529-1537. doi: 10.1001/jamaoncol.2017.1609.
5
A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System.美国军事医疗体系中非小细胞肺癌患者死亡率预测预后模型。
J Thorac Oncol. 2015 Dec;10(12):1694-702. doi: 10.1097/JTO.0000000000000691.
6
Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.整合肿瘤和基质基因表达特征与临床指标用于早期非小细胞肺癌生存分层
J Natl Cancer Inst. 2015 Aug 18;107(10). doi: 10.1093/jnci/djv211. Print 2015 Oct.
7
Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.肿瘤内信号熵决定乳腺癌和肺癌的临床结局。
PLoS Comput Biol. 2015 Mar 20;11(3):e1004115. doi: 10.1371/journal.pcbi.1004115. eCollection 2015 Mar.
8
The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer.
Int J Clin Oncol. 2015 Feb;20(1):59-69. doi: 10.1007/s10147-014-0700-8. Epub 2014 Jun 6.
9
Adaptive prediction model in prospective molecular signature-based clinical studies.前瞻性分子特征临床研究中的自适应预测模型。
Clin Cancer Res. 2014 Feb 1;20(3):531-9. doi: 10.1158/1078-0432.CCR-13-2127. Epub 2013 Dec 9.
本文引用的文献
1
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies.一种实用的分子检测方法，可预测非小细胞肺癌（非鳞癌）切除术后的生存情况：开发和国际验证研究。
Lancet. 2012 Mar 3;379(9818):823-32. doi: 10.1016/S0140-6736(11)61941-7. Epub 2012 Jan 27.
2
Cancer statistics, 2012.癌症统计数据，2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
3
Reduced lung-cancer mortality with low-dose computed tomographic screening.低剂量计算机断层扫描筛查可降低肺癌死亡率。
N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
4
Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.基于大系列全组织切片的肺腺癌和肺鳞癌鉴别免疫组化算法，并在小标本中进行验证。
Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.
5
Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing.小活检和细胞学肺癌的病理诊断和分类：用于分子检测的组织的策略性管理。
Semin Respir Crit Care Med. 2011 Feb;32(1):22-31. doi: 10.1055/s-0031-1272866. Epub 2011 Apr 15.
6
Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.核受体表达为肺癌定义了一组预后生物标志物。
PLoS Med. 2010 Dec 14;7(12):e1000378. doi: 10.1371/journal.pmed.1000378.
7
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.醛脱氢酶活性通过依赖于 Notch 信号的方式选择肺腺癌细胞干细胞。
Cancer Res. 2010 Dec 1;70(23):9937-48. doi: 10.1158/0008-5472.CAN-10-0881. Epub 2010 Nov 30.
8
Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.用于非小细胞肺癌根治术后辅助化疗的预后和预测基因标志物。
J Clin Oncol. 2010 Oct 10;28(29):4417-24. doi: 10.1200/JCO.2009.26.4325. Epub 2010 Sep 7.
9
Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.预测辅助化疗反应的非小细胞肺癌mRNA表达特征
J Clin Oncol. 2010 Oct 10;28(29):4404-7. doi: 10.1200/JCO.2010.31.0144. Epub 2010 Sep 7.
10
Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer.在非小细胞肺癌的吸烟者中，存在假定的肿瘤起始祖细胞群体预示着不良预后。
Cancer Res. 2010 Aug 15;70(16):6639-48. doi: 10.1158/0008-5472.CAN-10-0455.
Zotero 插件